RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Newer Horizon of Mesenchymal Stem Cell-Based Therapy in the Management of SARS-CoV-2-Associated Mucormycosis: A Safe Hope for Future Medicine.

Newer Horizon of Mesenchymal Stem Cell-Based Therapy in the Management of SARS-CoV-2-Associated Mucormycosis: A Safe Hope for Future Medicine.

Add to Collection
2021 Others A Raghav, SG Ali, GB Jeong, KA Gautam… - Frontiers in …, 2021 - frontiersin.org

Full Author : ['Raghav, Alok', 'Ali, Syed Ghazanfar', 'Jeong, Goo-Bo', 'Gautam, Kirti Amresh', 'Banday, Shahid', 'Mateen, Qazi Noorul', 'Tripathi, Prashant', 'Giri, Richa', 'Agarwal, Saurabh', 'Singh, Manish', 'Khan, Haris M']
Journal Title : Frontiers in microbiology
Chapter : Section4, Section8
Journal Year : 2021
Cited by : 2

SARS-CoV-2-infected patients are reported to show immunocompromised behavior that gives rise to a wide variety of complications due to impaired innate immune response, cytokine storm, and thrombo-inflammation. Prolonged use of steroids, diabetes mellitus,..... Read More

Keywords : ['mesenchymal stem cellbase therapy', 'safe hope', 'new horizon', 'future medicine', 'mucormycosis', 'management']
PubMed Link : https://www.frontiersin.org/articles/10.3389/fmicb.2021.738983/full
Google Scholar Link : https://scholar.google.com/scholar?cites=9268995712603259838&as_sdt=5,50&sciodt=0,50&hl=en&num=20